- 272 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Cancer Vaccines as Immunotherapy of Cancer
About this book
Cancer Vaccines as Immunotherapy of Cancer provides extensive and state-of-the-art information about the meaning, relevance and limitation of therapeutic cancer vaccines. It covers all the aspects involved in the vaccine research and development (identification of optimal target antigens, formulations, delivery strategies, adjuvants among others) as well as their use in combination with other immunomodulatory approaches.
The book discusses topics such as identification of tumor associated and specific antigens, proteogenomic for identification of novel target tumor antigens, antigen-specific T cells, and Peptide and RNA based vaccines. Additionally, it covers oncolytic viruses for antigen delivery, cancer vaccine targeting viral antigens and combinatorial immunotherapy strategies.
Written by leading experts worldwide, this is a valuable resource for cancer researchers, oncologists and members of biomedical field who wants to understand in depth the recent findings in the field of cancer vaccines.
- Describes the state-of-the-art of the research and development of therapeutic cancer vaccines
- Presents detailed diagrams to help the reader understand the functionality of each type of vaccine discussed
- Encompasses recent findings in the field through chapters written by leading experts worldwide
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Cancer Vaccines as Immunotherapy of Cancer by Luigi Buonaguro,Sjoerd Van Der Burg in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Biology. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Cover
- Title page
- Table of Contents
- Copyright
- Contents
- List of contributors
- About the editors
- Preface
- List of Illustrations
- List of Tables
- Chapter 1 : Oncolytic viruses for antigen delivery
- Chapter 2 : Tumor lysates cancer vaccine
- Chapter 3 : Tumor antigens for preventative cancer vaccines
- Chapter 4 : Regulatory aspects of cancer immunotherapy in Europe
- Chapter 5 : Identification of tumor antigens for T-cell-mediated cancer immunotherapy
- Chapter 6 : Therapeutic cancer vaccines targeting viral antigens
- Chapter 7 : Novel dendritic cell vaccine strategies
- Chapter 8 : Combinatorial immunotherapy strategies for cancer vaccines
- Chapter 9 : Peptide-based vaccines
- Chapter 10 : Personalized peptide vaccines
- Chapter 11 : Antigen-specific T cells
- Chapter 12 : Adjuvants for improving cancer vaccines
- Chapter 13 : Nucleic acid-based vaccines
- Index
- A